↓ Skip to main content

A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity

Overview of attention for article published in BMC Cancer, March 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

patent
4 patents

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity
Published in
BMC Cancer, March 2015
DOI 10.1186/s12885-015-1140-1
Pubmed ID
Authors

Lily Liu, Haijia Yu, Xin Huang, Hongzhi Tan, Song Li, Yan Luo, Li Zhang, Sumei Jiang, Huifeng Jia, Yao Xiong, Ruliang Zhang, Yi Huang, Charles C Chu, Wenzhi Tian

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 20%
Student > Ph. D. Student 4 13%
Researcher 3 10%
Student > Master 3 10%
Lecturer 2 7%
Other 2 7%
Unknown 10 33%
Readers by discipline Count As %
Medicine and Dentistry 5 17%
Pharmacology, Toxicology and Pharmaceutical Science 4 13%
Biochemistry, Genetics and Molecular Biology 4 13%
Agricultural and Biological Sciences 4 13%
Immunology and Microbiology 1 3%
Other 2 7%
Unknown 10 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 March 2024.
All research outputs
#4,749,004
of 22,992,311 outputs
Outputs from BMC Cancer
#1,224
of 8,355 outputs
Outputs of similar age
#60,017
of 263,826 outputs
Outputs of similar age from BMC Cancer
#34
of 238 outputs
Altmetric has tracked 22,992,311 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,355 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,826 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 238 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.